ACHIEVEMENTS

研究業績

  • 論文2022.07.24

    HTLV-1 intragenic viral enhancer influences immortalization phenotype in vitro, but is dispensable for persistence and disease development in animal models

    V. Maksimova et al, Frontiers in Immunology, Vol.13, 954077 (2022)
    https://doi.org/10.3389/fimmu.2022.954077
  • 論文2022.07.20

    Maternal embryonic leucine zipper kinase (MELK) optimally regulates the HIV-1 uncoating process

    T. Nishiyama et al., PLOS Computational Biology, Vol. 545, No. 4, 111152 (2022)
    https://doi.org/10.1016/j.jtbi.2022.111152
  • 論文2022.07.18

    Genome-wide CRISPR screen for HSV-1 host factors reveals PAPSS1 contributes to heparan sulfate synthesis

    T. Suzuki et al., Communications Biology, Vol. 5, No. 1, 694 (2022)
    https://doi.org/10.1038/s42003-022-03581-9
  • 講演2022.07.05

    HIVウイルスリザーバー:現状と課題

    佐藤賢文, ギリアド・サイエンシズ株式会社主催　第2回 Next Generation Meeting
  • 講演2022.07.02

    高速リバースジェネティクスのIRES依存 +ssRNAウイルスへの応用

    田村友和, 日本ウイルス学会北海道支部会 第55回夏季シンポジウム
  • 論文2022.06.30

    IFN-γ‒Induced APOBEC3B Contributes to Merkel Cell Polyomavirus Genome Mutagenesis in Merkel Cell Carcinoma

    L. Que et al., J Invest Dermatol, Vol.142, No. 7, pp. 1793-1803 (2022)
    https://doi.org/10.1016/j.jid.2021.12.019
  • 論文2022.06.30

    Parental Population Range Expansion before Secondary Contact Promotes Heterosis

    A. MacPherson et al., The American Naturalist, Vol. 200, No. 1, pp. E1-E15 (2022)
    https://doi.org/10.1086/719656
  • 論文2022.06.30

    Antiviral activity of ciclesonide acetal derivatives blocking SARS-CoV-2 RNA replication

    G. Tsuji et al, J Pharmacol Sci., Vol. 149, No. 3, pp 81-84 (2022)
    https://doi.org/10.1016/j.jphs.2022.04.001
  • 講演2022.06.30

    デジタルツイン時代のCOVID-19研究

    岩見真吾, 第49回日本毒性学会学術年会 シンポジウム
  • 講演2022.06.24

    流体解析の循環器への応用

    板谷慶一, 第132回日本循環器学会九州地方会
  • 論文2022.06.22

    Impact of JMJD6 on intrahepatic cholangiocarcinoma

    Y. Kosai-Fujimoto et al., Mol Clin Oncol., Vol. 17, No. 2, 131 (2022)
    https://doi.org/10.3892/mco.2022.2564
  • 論文2022.06.20

    Novel Neplanocin A Derivatives as Selective Inhibitors of Hepatitis B Virus with a Unique Mechanism of Action

    M. Toyama et al, Antimicrobial Agents and Chemotherapy, Vol. 66, No. 6, e0207321 (2022)
    https://doi.org/10.1128/aac.02073-21
  • 講演2022.06.18

    ウイルス学を基軸とした抗ウイルス薬研究

    渡士幸一, 日本臨床ウイルス学会
  • 講演2022.06.18

    COMMUNITY-ACQUIRED PNEUMONIA (CAP) INCIDENCE IN ADULTS 18 YEARS AND OLDER IN GOTO CITY, JAPAN - RESULTS FROM A POPULATION-BASED PROSPECTIVE STUDY

    T. Miyazaki et al., 12th International Symposium on Pneumococci and Pneumococcal Disease
  • 講演2022.06.18

    SEROTYPE AND ANTIMICROBIAL CHARACTERISTICS OF STREPTOCOCCUS PNEUMONIAE ISOLATES CULTURED FROM JAPANESE ADULT PATIENTS WITH COMMUNITY-ACQUIRED PNEUMONIA (CAP) IN GOTO CITY, JAPAN

    T. Miyazaki, 12th International Symposium on Pneumococci and Pneumococcal Diseases
  • 講演2022.06.18

    抗ウイルス薬の開発について ～臨床医の視点から～

    宮崎泰可, 日本臨床ウイルス学会
  • 講演2022.06.18

    デジタルツイン時代の感染症創薬研究

    岩見真吾, 第63回 日本臨床ウイルス学会 シンポジウム4
  • 論文2022.06.13

    Significant role of host sialylated glycans in the infection and spread of severe acute respiratory syndrome coronavirus 2

    W. Saso et al., PLoS Pathogens, Vol.18, No. 6, e1010590 (2022)
    https://doi.org/10.1371/journal.ppat.1010590
  • 論文2022.06.08

    Virological characteristics of the SARS-CoV-2 Omicron BA.2 spike

    D. Yamasoba et al, Cell, Vol.185, No. 12, pp. 2103-2115 (2022)
    https://doi.org/10.1016/j.cell.2022.04.035
  • 講演2022.06.05

    Topological Flow Data Analysis for Blood Flows Insider a Heart

    Takashi Sakajo, The 1st International Symposium on Aihara Moonshot Project
1
2
3
4
5
6
7
8
9
10

11

12
13

JST-MIRAI Project Four-Dimensional Topological Data Analysis for Future Medical Care